Atlas Trials

Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

Clinical trial NCT05870007 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05870007
Sponsor
Taipei Medical University Shuang Ho Hospital
Status
ENROLLING_BY_INVITATION
Phase
Phase 2
Study type
INTERVENTIONAL
Autosomal Dominant Polycystic Kidney DiseaseChronic Kidney Diseases
Start date
2023-05-01
Primary completion
2025-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.